The Director of Scientific Communications & Medical Information at Meitheal Pharmaceuticals is responsible for leading the strategic development, implementation, and execution of scientific communication and medical information activities. This role is critical in ensuring that internal and external stakeholders receive timely, accurate, and impactful scientific information across all therapeutic areas, specifically focusing on Meitheal’s infectious disease portfolio, including CONTEPO (IV Fosfomycin) and XENLETA (IV and oral Lefamulin acetate), oncology and other biosimilar immunologic therapies, and numerous pipeline assets, some of which may include E.U. and other ex-U.S. territories.
A Smarter and Faster Way to Build Your Resume